← FDA DRUG APPROVALS

FDA ANDA · ANDA091605

DOXYCYCLINE

Sponsor: HERITAGE

APPLICATION
ANDA091605
TYPE
ANDA
ORIGINAL APPROVAL
2011-12-20
LATEST ACTION
2015-01-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

DOXYCYCLINEPrescription
DOXYCYCLINE EQ 100MG BASE · TABLET · ORAL
DOXYCYCLINEPrescription
DOXYCYCLINE EQ 50MG BASE · TABLET · ORAL
DOXYCYCLINEPrescription
DOXYCYCLINE EQ 150MG BASE · TABLET · ORAL
DOXYCYCLINEPrescription
DOXYCYCLINE EQ 75MG BASE · TABLET · ORAL

Approval history

2015-01-20Labeling · Supplement 2 · standardAP
2011-12-20Not Applicable · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →